Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...

Transcranial magnetic stimulation for alcohol use disorders is under investigation. Research to date suggests TMS could play ...

Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel ...

"This is an area in which we haven't had something we felt hopeful about in a while," professor Joseph Schacht said.

Joe Breen, 38, is one of thousands of people whose experiences with GLP-1s such as Ozempic and Wegovy have radically changed their relationship with alcohol. Are these drugs the future for treating ...

A new study shows that a single dose of CBD may reduce alcohol cravings, offering the first clinical evidence that it could ...

Transcranial magnetic stimulation, or "TMS," is an FDA-approved psychiatric treatment for major depressive disorder and obsessive-compulsive disorder (OCD), with intriguing clinical trials ...

The GLP-1 medications have been linked to decreased risks of heart disease, kidney disease and Alzheimer’s disease, as well as increased fertility and a reduction in alcohol cravings.